RESEARCH HIGHLIGHT

29 May 2026

Death and the need for liver transplant were delayed in people with cirrhosis who received macrophage therapy.

Cirrhosis causes severe scarring of the liver (pictured, liver cells from a person with the disease). Credit: Microscape/SPL

Infusions of immune cells called macrophages have been linked to a reduction in the risk of death and the need for a liver transplant in people with cirrhosis 1 .

Access options

Access Nature and 54 other Nature Portfolio journals

Get Nature+, our best-value online-access subscription

$32.99 / 30 days

cancel any time

Subscribe to this journal

Receive 52 print issues and online access

$199.00 per year

only $3.83 per issue

Rent or buy this article

Prices vary by article type

from $1.95

to $39.95

Prices may be subject to local taxes which are calculated during checkout

Additional access options:

Log in

Learn about institutional subscriptions

Read our FAQs

Contact customer support

doi:…